|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Traditional Japanese Medicine,Kampo:Its History and Current Status显示文摘Traditional Japanese medicine,Kampo,is used by over 80%of medical doctors in Japan.Owing to its high quality and safety,Kampo has been integrated into modern medicine,and there are 345 randomized controlled trials using Kampo in Japan as of 2010.Although there are a number of articles in top journals about basic science research,we can find only small numbers of high-quality clinical evidence.Since undergraduate education on Kampo has been established,integrative approach with the balanced combination of modern medicine and Kampo is expected to generate good clinical evidence in the near future. | Yoshiharu Motoo Takashi Seki Kiichiro Tsutani | 2011 | Chinese Journal of Integrative Medicine2011，17，3： | 3 |
| 2 | 日本传统汉方医学文献的重复发表案例(英文)显示文摘目的:文献的重复发表对于科学及出版业都有不利的影响。在整理日本东洋医学会循证医学特别委员会出版的汉方治疗证据报告(Evidence Reports of Kampo Treatment,EKAT)2009的过程中,我们发现了一些重复发表的文献案例。因此,我们检查了所有EKAT2009中的文献并分析了重复发表文献是如何产生的。方法:EKAT2009中共有320个随机对照试验研究的结构式摘要。我们检查了这320个摘要所参考的384篇文献,并根据如下标准定义重复发表文献:假说及结果雷同,作者一致,没有说明为二次出版文献,没有交叉引用相关文献。结果:我们最终确认在EKAT2009中共有11篇重复发表文献。这些重复发表文献可以分为以下四类:与已发表文献的样本数据及结果完全雷同(n=3);添加了新的样本数据,但结果与已发表文献雷同(n=1);报告前期已发表文献的一部分样本数据,但结果雷同(n=1);将已发表文献翻译为另外一种语言再次发表(n=6)。结论:EKAT2009中的11篇重复发表文献有四种不同形式,这四种形式反映了日本汉方医学研究领域的研究者发表重复文献的主要行为模式,即完善之前已发表的文献投稿至更好的杂志或是将原来英文发表的文献翻译为日文再次发表。为了提高研究者们对于重复发表的认识程度,应该对其进行更多的出版道德普及。 | Masamichi Kitagawa Kiichiro Tsutani | 2011 | 中西医结合学报2011，9，10： | 2 |
| 3 | Medicinal herbs for hepatitis C virus infection :a Cochrane hepatobiliary systematic review of randomized trials显示文摘 | Liu J Manheimer E Tsutani K | 2003 | Am J Gastroenterol2003，98，3： | 1 |
| 4 | Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer显示文摘 | Tsutani Y Ohara M Suzuki T | 2009 | Anticancer Res2009，29，7： | 1 |
| 5 | Development of a Mobile Inspection Robot for Power Transmission Lines 显示文摘 | HIGUCHI M MAEDA Y TSUTANI S | 1991 | Journal of the Robotics Society of Japan1991，9，4： | 1 |
| 6 | Neutrophilelastase induces cell proliferation and migration by the release of TGF-alpha,PDGF and VEGF in esophageal celllings显示文摘 | WadaY Yoshida K Tsutani Y | 2007 | Oncol Rep2007，17，1： | 1 |
| 7 | Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: Prognostic comparison using high-resolution computed tomography findings 显示文摘 | Tsutani Y Miyata Y Yamanaka T | 2013 | J Thorac Cardiovasc Surg2013，146，1： | 1 |
| 8 | The inflammatory pro- cess in the mechanism of decreased serum uric acid concentra- tions during acute gouty arthritis 显示文摘 | Urano W Yamanaka H Tsutani H | 2002 | The Journal of rheumatology2002，29，9： | 1 |
| 9 | Medicinal herbs for hepatitis C virus infection:a Cochran hepatobiliary systematic review of randomized trials显示文摘 | Liu J Manheimer E Tsutani K | 2003 | Am J Gastroenterol2003，98，： | 1 |
| 10 | Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer显示文摘 | Ohara M Shigematsu H Tsutani Y | 2013 | Breast2013，22，5： | 1 |
| 11 | Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage I A lung adenocarcinoma:wedge resection or seg-mentectomy显示文摘 | Tsutani Y Miyata Y Nakayama H | 2014 | Chest2014，，145： | 1 |
| 12 | Development of a mobile inspection robot for power transmission lines显示文摘 | Higuchi M Maeda Y Tsutani S | 1991 | Journal of the Robotics Society of Japan1991，9，4： | 1 |
| 13 | Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma显示文摘 | Uehara H Tsutani Y Okumura S | 2013 | Ann Thorac Surg2013，96，6： | 1 |
| 14 | Oncologic out- comes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score- matched analysis in a multicenter study显示文摘 | Tsutani Y Miyata Y Nakayama H | 2013 | J Thorac Cardiovasc Surg2013，146，2： | 1 |
| 15 | Prediction of pathologic node-negative clinical stage IA lung adenocar- cinoma for optimal candidates undergoing sublobar resec- tion显示文摘 | Tsutani Y Miyata Y Nakayama H | 2012 | J Thorac Cardiovasc Surg2012，144，6： | 1 |
| 16 | The prognostic role of pathologic invasive component size,excluding lepidic growth,in stage I lungadenocarcinoma显示文摘 | Tsutani Y Miyata Y Mimae T | 2013 | J Thorac Cardiovasc Surg2013，146，3： | 1 |
| 17 | Approval of new biopharmaceuticals 1999- 2006:comparison of the US,EU and Japan situations显示文摘 | Tsuji K Tsutani K | 2008 | Eur J Pharm Biopharm2008，68，3： | 1 |
| 18 | Use of High-Resolution Computed Tomography and Positron Emission Tomography/Computed Tomography in the Management of Stage IA Adenocarcinoma 显示文摘 | Miyata Y Tsutani Y Okada M | 2012 | Semin Thoracic Surg2012，24，4： | 1 |
| 19 | Discordant LFA-1/ICAM-1 expression in a case of secondary plasma cell leukemia associated with subcutaneous plasmacytoma显示文摘 | Sugiyama T Shimizu S | 1993 | Am J Hematol1993，42，3： | 1 |
| 20 | Prediction of pathologic node-negative clinical stage IA lungadenocarcinoma for optimal candidates undergoingsublobar resection 显示文摘 | Tsutani Y Miyata Y Nakayama H | 2012 | J Thorac Cardiovasc Surg2012，144，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员